OTCMKTS:BGMDBG Medicine Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BG Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.03 0.00 (0.00 %) (As of 04/7/2020 04:23 AM ET) Add Compare Share Today's Range$0.03Now: $0.03▼$0.0350-Day Range$0.02MA: $0.02▼$0.0552-Week Range$0.01Now: $0.03▼$0.05VolumeN/AAverage Volume12,452 shsMarket Capitalization$341,100.00P/E RatioN/ADividend YieldN/ABeta1.17 ProfileAdvanced ChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for BG Medicine. Previous Next 2.3 Community Rank Outperform VotesBG Medicine has received 91 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBG Medicine has received 104 “underperform” votes. (Add your “underperform” vote.)Community SentimentBG Medicine has received 53.33% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote “Outperform” if you believe BGMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BGMD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBG Medicine does not currently pay a dividend.Dividend GrowthBG Medicine does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BG Medicine insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.50% of the stock of BG Medicine is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Diagnostic substances Sub-IndustryLife Sciences Tools & Services SectorMedical Current SymbolOTCMKTS:BGMD Previous SymbolNASDAQ:BGMD CUSIP08861T10 CIK1407038 Webhttp://www.bg-medicine.com/ Phone781-890-1199Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees5 Outstanding Shares11,370,000Market Cap$341,100.00 Next Earnings DateN/A OptionableNot Optionable Receive BGMD News and Ratings via Email Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter. OTC:BGMD Rates by TradingView BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions How has BG Medicine's stock been impacted by COVID-19 (Coronavirus)? BG Medicine's stock was trading at $0.0151 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BGMD shares have increased by 98.7% and is now trading at $0.03. View which stocks have been mosted impacted by Coronavirus. How were BG Medicine's earnings last quarter? BG Medicine, Inc. (OTCMKTS:BGMD) posted its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share for the quarter. The medical research company had revenue of $334 million for the quarter, compared to the consensus estimate of $695 million. View BG Medicine's earnings history. Has BG Medicine been receiving favorable news coverage? News articles about BGMD stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BG Medicine earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutBG Medicine. Who are some of BG Medicine's key competitors? Some companies that are related to BG Medicine include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Bruker (BRKR), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE). What other stocks do shareholders of BG Medicine own? Based on aggregate information from My MarketBeat watchlists, some companies that other BG Medicine investors own include NovaBay Pharmaceuticals (NBY), AEterna Zentaris (AEZS), Glu Mobile (GLUU), Blue Ridge Mountain Resources (MHRCQ), Arca Biopharma (ABIO), Athersys (ATHX), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), Inpixon (INPX) and LightPath Technologies (LPTH). Who are BG Medicine's key executives? BG Medicine's management team includes the following people: Dr. Paul R. Sohmer, CEO, Pres & Director (Age 70)Mr. Stephen P. Hall, CFO, Exec. VP & Treasurer (Age 68)Dr. Aram Adourian, Chief Scientific Officer (Age 49) What is BG Medicine's stock symbol? BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD." How do I buy shares of BG Medicine? Shares of BGMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BG Medicine's stock price today? One share of BGMD stock can currently be purchased for approximately $0.03. How big of a company is BG Medicine? BG Medicine has a market capitalization of $341,100.00. BG Medicine employs 5 workers across the globe. View additional information about BG Medicine. What is BG Medicine's official website? The official website for BG Medicine is http://www.bg-medicine.com/. How can I contact BG Medicine? BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected] This page was last updated on 4/7/2020 by MarketBeat.com StaffFeatured Article: Understanding Price to Earnings Ratio (PE)
